Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 35.95 | N/A |
| PEG Ratio (TTM) | -0.98 | N/A |
| P/S Ratio (TTM) | 0.28 | N/A |
| P/B Ratio (TTM) | 0.85 | N/A |
| P/FCF Ratio (TTM) | 8.09 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.75 | N/A |
| Price to 5YR AVG FCF Ratio | -20.83 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.12% | N/A |
| ROE (TTM) | 2.38% | N/A |
| Net Profit Margin (TTM) | 0.78% | N/A |
| ROIC 5YR AVG | 7.11% | N/A |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -6.91% | 42.59% | 29.01% |
| Revenue | -3.68% | 4.55% | 8.56% |
| Net Income | -7.56% | 41.60% | 28.04% |
| Cash Flow | -23.45% | 364.57% | 361.50% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.28 | N/A |
| Quick Ratio (TTM) | 1.30 | N/A |
| D/E Ratio (TTM) | 0.45 | N/A |
| Interest Coverage (TTM) | 2.77 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.85 | N/A |
| LTL to 5YR AVG FCF | -10.67 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.60% | N/A |